目的 對(duì)咸陽(yáng)市中心醫(yī)院2019—2021年麻醉藥品使用情況匯總，分析麻醉藥品使用的規(guī)范性及合理性。方法 對(duì)2019—2021年咸陽(yáng)市中心醫(yī)院麻醉藥品的銷(xiāo)售金額、用藥頻度（DDDs）、日均費(fèi)用（DDC）及藥品排序比（B/A）等進(jìn)行統(tǒng)計(jì)和分析。結(jié)果 咸陽(yáng)市中心醫(yī)院常用麻醉藥品11種，全年臨床使用金額呈小幅增長(zhǎng)趨勢(shì)，DDDs排前4位的分別是枸櫞酸舒芬太尼注射液、枸櫞酸芬太尼注射液（0.1、0.5 mg）以及注射用鹽酸瑞芬太尼。DDC排前3位的分別是鹽酸羥考酮緩釋片（10、40 mg）以及硫酸嗎啡緩釋片。枸櫞酸芬太尼注射液（0.1、0.5 mg）、枸櫞酸舒芬太尼注射液的B/A值都大于1。結(jié)論 咸陽(yáng)市中心醫(yī)院麻醉藥品品規(guī)結(jié)構(gòu)合理，能滿足患者的醫(yī)療需求，藥品使用較為穩(wěn)定、合理。

Objective To summarize the use of narcotic drugs in Xianyang Central Hospital from 2019 to 2021, and analyze the standardization and rationality of the use of narcotic drugs. Methods A retrospective study was conducted. The data of utilization of narcotic analgesic drugs in Xianyang Central Hospital from 2019 to 2021 were collected and statistically analyzed, and consumption sums, frequency of drug use (DDDs), defined daily cost (DDC), and drug sequence ratio (B/A) were calculated and analyzed. Results There were 11 commonly used narcotic drugs in Xianyang Central Hospital, and the annual clinical consumption showed a slight increase trend. The top 4 drugs in DDDs were Sufentanil Citrate Injection, Fentanyl Citrate Injection (0.1, 0.5 mg), and Remifentanil Hydrochloride for injection. The top 3 DDC were Oxycodone Hydrochloride Sustained-Release Tablets (10, 40 mg) and Morphine Sulfate Sustained-Release Tablets, respectively. The B/A values of Fentanyl Citrate Injection (0.1, 0.5 mg) and Sufentanil Citrate Injection were all above 1. Conclusion Narcotic drug product regulation structure of Xianyang Central Hospital is reasonable, can meet the medical needs of patients, and drug use is relatively stable and reasonable.

R971